Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP624959.RAeORht_l9cIJTvcmguXn0sJ3DPEpgcxAS9pl-Kzmm7p0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP624959.RAeORht_l9cIJTvcmguXn0sJ3DPEpgcxAS9pl-Kzmm7p0130_assertion type Assertion NP624959.RAeORht_l9cIJTvcmguXn0sJ3DPEpgcxAS9pl-Kzmm7p0130_head.
- NP624959.RAeORht_l9cIJTvcmguXn0sJ3DPEpgcxAS9pl-Kzmm7p0130_assertion description "[Comparison of Burkitt's lymphoma-derived Akata, Mutu-I, and Daudi cells, which are representative responders and nonresponders to BCR-mediated EBV activation, respectively, indicated that three signaling pathways, phosphatidylinositol 3-kinase (PI3K), extracellular signal-regulated kinase (ERK), and p38 mitogen-activated protein kinase (MAPK), were activated in anti-Ig-treated Akata and Mutu-I cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624959.RAeORht_l9cIJTvcmguXn0sJ3DPEpgcxAS9pl-Kzmm7p0130_provenance.
- NP624959.RAeORht_l9cIJTvcmguXn0sJ3DPEpgcxAS9pl-Kzmm7p0130_assertion evidence source_evidence_literature NP624959.RAeORht_l9cIJTvcmguXn0sJ3DPEpgcxAS9pl-Kzmm7p0130_provenance.
- NP624959.RAeORht_l9cIJTvcmguXn0sJ3DPEpgcxAS9pl-Kzmm7p0130_assertion SIO_000772 14734735 NP624959.RAeORht_l9cIJTvcmguXn0sJ3DPEpgcxAS9pl-Kzmm7p0130_provenance.
- NP624959.RAeORht_l9cIJTvcmguXn0sJ3DPEpgcxAS9pl-Kzmm7p0130_assertion wasDerivedFrom befree-20150227 NP624959.RAeORht_l9cIJTvcmguXn0sJ3DPEpgcxAS9pl-Kzmm7p0130_provenance.
- NP624959.RAeORht_l9cIJTvcmguXn0sJ3DPEpgcxAS9pl-Kzmm7p0130_assertion wasGeneratedBy ECO_0000203 NP624959.RAeORht_l9cIJTvcmguXn0sJ3DPEpgcxAS9pl-Kzmm7p0130_provenance.